Eclipse Bioinnovations

About:

Eclipse Bioinnovations is an RNA genomics company that provides products and services to academic and industry customers around the world.

Website: https://www.eclipsebio.com/

Twitter/X: bio_eclipse

Top Investors: Alexandria Venture Investments, Phoenix Venture Partners, iGlobe, Photon Venture Alpha

Description:

Eclipse Bioinnovations is a leading RNA genomics company founded in 2017 based on technology developed at the University of California, San Diego. Eclipse's mission is to use their pioneering RNA genomics platform technologies to advance RNA medicines and scientific discovery. Eclipse’s founders developed eCLIP, the world’s most efficient and unique CLIP-seq technology for identifying RNA binding protein gene partners and gene maps. Eclipse’s suite of RNA genomics technologies now cover eCLIP-RBP for mapping the RNA binding proteins, miR-eCLIP for the miR-interactome, m6A-eCLIP for RNA modifications, End-Seq for 5' and 3' mapping, and FLI-Seq for simplifying Crispr library prep. Products are offered as services and kit for biopharma companies and academic researchers, and can be customized for clients.